Australia markets closed

Amplia Therapeutics Limited (ATX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0650+0.0010 (+1.56%)
At close: 10:35AM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 12.98M
Enterprise value 9.56M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.88
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.23

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-38.10%
S&P500 52-week change 321.08%
52-week high 30.1150
52-week low 30.0550
50-day moving average 30.0749
200-day moving average 30.0792

Share statistics

Avg vol (3-month) 387.84k
Avg vol (10-day) 3219.7k
Shares outstanding 5199.62M
Implied shares outstanding 6199.62M
Float 8117.39M
% held by insiders 115.05%
% held by institutions 116.53%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 330 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -238.69%
Operating margin (ttm)-47.42%

Management effectiveness

Return on assets (ttm)-14.40%
Return on equity (ttm)-26.40%

Income statement

Revenue (ttm)1.87M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)38.40%
Gross profit (ttm)N/A
EBITDA -4.51M
Net income avi to common (ttm)-4.46M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.66M
Total cash per share (mrq)0.03
Total debt (mrq)2.24M
Total debt/equity (mrq)15.18%
Current ratio (mrq)3.43
Book value per share (mrq)0.08

Cash flow statement

Operating cash flow (ttm)-5.9M
Levered free cash flow (ttm)-4.38M